Psychemedics
0
Product was successfully added to your cart
  • No products in the cart.
Customer Log-In Investor Relations
877-517-2033
  • About
    • Scientific Leadership
    • Why Choose PMD Hair
    • Innovations
    • A Message From Our CEO
  • Products
    • Drug Panel
    • Workplace Drug Testing
    • School Drug Testing
    • Personal Drug Testing
    • Alcohol Testing
    • Instant Testing
    • Contractor Compliance
  • Technology
    • The Importance of Effective Drug Testing
    • The Science Behind Hair Analysis
    • Why Hair Over Urinalysis Testing
    • All Hair Drug Testing Is Not The Same
    • Words of Caution
  • Resources
    • Blog
    • Press Releases
    • Newsletters
    • Case Studies
    • Testimonials
    • FAQs
  • Collections
  • Contact
    • Sales
    • Client Services
    • Corporate
    • International
    • For Our Clients
IR Menu
  • Corporate Information
    • Corporate Profile
    • Officers & Directors
    • Governance Documents
    • Committee Charting
  • Stock Information
    • Stock Quote
    • Historic Prices
    • Financial Calculators
  • SEC Filings & Press Releases
    • Documents
    • Proxy
    • Insider Filings
    • Annual Reports
    • Event Calendar
    • News Releases
  • Other Information
    • Information Request
    • Email Notification
  • IR Site Map
Email page Email page
PDF view PDF view Print view Print view Email Alert Email Alert

Information Request

Information Request

Corporate Headquarters:

289 Great Road, Suite 200
Acton, MA 01720
(800) 628-8073

This form submits information via e-mail which is inherently insecure. Please do not include ANY personal information that you do not wish to be shared with others.


Required Field
Copyright 2019, © S&P Global Market Intelligence  Terms of Use

TERMS AND CONDITIONS OF USE

PDF View Print View

The investor relations site ("Site") with which this document is associated is maintained by S&P Global Market Intelligence ("S&P") on behalf of the organization featured on the Site (S&P's "Client"). These Terms and Conditions of Use ("Terms of Use") set forth the terms on which you may use the Site, and the information and materials contained therein (the "Contents"). By using the Site, you agree to these Terms of Use. If you do not agree to these Terms of Use, you are not authorized to use the Site or Contents in any manner, and you should immediately discontinue any use of the Site or the Contents.

S&P and/or its Client shall have the right at any time to modify or discontinue any aspect of the Site or any part of the Contents. S&P may also modify these Terms of Use without notice. You agree to monitor these Terms of Use, and to cease all access or use of the Site if you no longer agree to abide by the Terms of Use. Your continued use of the Site shall constitute acceptance of such modification.

S&P and the Client grant to you a limited, personal license to access the Site and to access and download the Contents, but only for your own personal, family and household use. You may not use, reproduce, distribute or display any portion of the Site for any other purpose, including without limit any commercial purpose. You may use the Site and the Contents for lawful purposes only. S&P and Client reserve all rights not expressly granted, including the right to terminate your use of the Site without notice.

The Site contains copyrighted material, trademarks and service marks, and other proprietary information, including but not limited to text, software, and graphics, which materials are owned by S&P and/or its Client. S&P and Client reserve all rights in the Contents. You agree not to reproduce, distribute, sell, broadcast, publish, retransmit, disseminate, circulate or commercially exploit the Site or the Contents without the express written consent of S&P and the Client.

You agree to access the Contents and the Site manually, by request, and not automatically, through the use of a program, or other means. You agree not to take any action, alone or with others, that would interfere with the operation of the Site, to alter the Site in any way, or to impede others' access to and freedom to enjoy and use the Site as made available by S&P and S&P’s Client.

THE SITE AND THE CONTENTS ARE PROVIDED ON AN "AS IS" BASIS. S&P, ITS CLIENT, AND ANY OTHER PROVIDERS OF THE INFORMATION EXPRESSLY DISCLAIM ALL WARRANTIES OF ANY KIND, EXPRESS OR IMPLIED, INCLUDING WITHOUT LIMITATION ANY WARRANTY OF ACCURACY, MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NON-INFRINGEMENT.

NEITHER, S&P, THE CLIENT NOR EITHER OF THEIR AFFILIATES, SHAREHOLDERS, OFFICERS, EMPLOYEES, AGENTS OR REPRESENTATIVES SHALL BE LIABLE FOR ANY INDIRECT, INCIDENTAL, EXEMPLARY , PUNITIVE SPECIAL OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR RELATING TO THE SITE, THE USE OF OR INABILITY TO USE THE SITE, OR THE CONTENTS, EVEN IF SUCH PARTY HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. IN PARTICULAR, S&P WILL NOT BE LIABLE FOR ANY LOSS OR DAMAGE CAUSED BY YOUR RELIANCE ON INFORMATION OBTAINED THROUGH THE SITE.

It is your responsibility to evaluate the accuracy, completeness or usefulness of any of the Contents available on the Site. Please seek the advice of professionals regarding the evaluation of any of the information on the Site.

The Site does not represent an offer or solicitation with respect to the purchase or sale of any security.

These Terms of Use are the entire agreement between the parties with respect to its subject matter, and it can be amended only via written agreement by S&P. These terms and conditions shall be governed by the law of New York, without regard to principals of conflicts or choice of laws.

Corporate Headquarters
289 Great Road, Suite 200
Acton, MA 01720
United States
(877) 517-2033

Psychemedics Corporation

© Copyright 2019 - Psychemedics Corporation
This site is governed solely by applicable U.S. laws and governmental regulations. Please see our Privacy Policy. Use of this site constitutes your consent to application of such laws and regulations and to our Privacy Policy. Your use of the information on this site is subject to the terms of our Legal Notice. You should view the Investor Relations section in order to receive the most current information made available by Psychemedics Corporation.